BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3342763)

  • 1. Inhibitory action of leumorphin on vasopressin secretion in conscious rats.
    Yamada T; Nakao K; Itoh H; Morii N; Shiono S; Sakamoto M; Sugawara A; Saito Y; Mukoyama M; Arai H
    Endocrinology; 1988 Mar; 122(3):985-90. PubMed ID: 3342763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leumorphin is a potent inhibitor of vasopressin secretion.
    Yamada T; Nakao K; Itoh H; Morii N; Shiono S; Sakamoto M; Sugawara A; Saito Y; Katsuura G; Eigyo M
    NIDA Res Monogr; 1986; 75():335-8. PubMed ID: 3123947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of leumorphin in inhibitory control of vasopressin secretion in conscious rats.
    Yamada T; Nakao K; Itoh H; Morii N; Shiono S; Sakamoto M; Sugawara A; Saito Y; Mukoyama M; Arai H
    Hypertension; 1988 Feb; 11(2 Pt 2):I80-3. PubMed ID: 3346067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid modulation of vasopressin secretion in conscious rats.
    Yamada T; Nakao K; Itoh H; Shirakami G; Sugawara A; Saito Y; Mukoyama M; Arai H; Hosoda K; Morii N
    Clin Exp Hypertens A; 1988; 10 Suppl 1():361-7. PubMed ID: 3243002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent depressor action of leumorphin, a kappa-opioid agonist, in conscious rats.
    Itoh H; Nakao K; Yamada T; Morii N; Shiono S; Sakamoto M; Sugawara A; Saito Y; Mukoyama M; Arai H
    Am J Hypertens; 1988 Jul; 1(3 Pt 1):256-61. PubMed ID: 2839205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of naloxone on vasopressin secretion in conscious rats: evidence for inhibitory role of endogenous opioid peptides in vasopressin secretion.
    Yamada T; Nakao K; Itoh H; Shirakami G; Sugawara A; Saito Y; Mukoyama M; Arai H; Hosoda K; Shiono S
    Endocrinology; 1989 Aug; 125(2):785-90. PubMed ID: 2546748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrally administered leumorphin possesses potent depressor activity in conscious rats.
    Itoh H; Nakao K; Yamada T; Morii N; Shiono S; Sakamoto M; Sugawara A; Saito Y; Katsuura G; Shiomi T
    NIDA Res Monogr; 1986; 75():512-5. PubMed ID: 3123970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent action of leumorphin on consummatory behaviors in rats: comparison with other opioid peptides.
    Imura H; Nakao K; Yanaihara N; Katsuura G; Nakamura M
    Neuroendocrinology; 1986; 44(2):142-8. PubMed ID: 3796789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrin-releasing peptide stimulation of corticotropin secretion in male rats.
    Olsen L; Knigge U; Warberg J
    Endocrinology; 1992 May; 130(5):2710-6. PubMed ID: 1315254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation by leumorphin of prolactin secretion from the pituitary in rats.
    Tojo K; Kato Y; Ohta H; Matsushita N; Shimatsu A; Kabayama Y; Inoue T; Yanaihara N; Imura H
    Endocrinology; 1985 Sep; 117(3):1169-74. PubMed ID: 2862017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic responses of conscious rats following intrathecal injections of prodynorphin-derived opioids: independence of action of intrathecal arginine vasopressin.
    Thornhill JA; Pittman QJ
    Can J Physiol Pharmacol; 1990 Feb; 68(2):174-82. PubMed ID: 1968777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible involvement of endogenous opioid peptides in the inhibition of arginine vasopressin release by gamma-aminobutyric acid in conscious rats.
    Otake K; Kondo K; Oiso Y
    Neuroendocrinology; 1991 Aug; 54(2):170-4. PubMed ID: 1766553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediation of the stress-induced prolactin release by hypothalamic histaminergic neurons and the possible involvement of vasopressin in this response.
    Kjaer A; Knigge U; Olsen L; Vilhardt H; Warberg J
    Endocrinology; 1991 Jan; 128(1):103-10. PubMed ID: 1986913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebroventricular injection of brain natriuretic peptide inhibits vasopressin secretion in conscious rats.
    Yamada T; Nakao K; Itoh H; Shirakami G; Kangawa K; Minamino N; Matsuo H; Imura H
    Neurosci Lett; 1988 Dec; 95(1-3):223-8. PubMed ID: 3226610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kappa-opioid modulation of vasopressin secretion in conscious rats.
    Wells T; Forsling ML
    J Endocrinol; 1991 Jun; 129(3):411-6. PubMed ID: 1648591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Centrally administered tuberoinfundibular peptide of 39 residues inhibits arginine vasopressin release in conscious rats.
    Sugimura Y; Murase T; Ishizaki S; Tachikawa K; Arima H; Miura Y; Usdin TB; Oiso Y
    Endocrinology; 2003 Jul; 144(7):2791-6. PubMed ID: 12810532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centrally administered parathyroid hormone (PTH)-related protein(1-34) but not PTH(1-34) stimulates arginine-vasopressin secretion and its messenger ribonucleic acid expression in supraoptic nucleus of the conscious rats.
    Yamamoto S; Morimoto I; Zeki K; Ueta Y; Yamashita H; Kannan H; Eto S
    Endocrinology; 1998 Jan; 139(1):383-8. PubMed ID: 9421437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endogenous nociceptin in the regulation of arginine vasopressin release in conscious rats.
    Kakiya S; Murase T; Arima H; Yokoi H; Iwasaki Y; Miura Y; Oiso Y
    Endocrinology; 2000 Dec; 141(12):4466-71. PubMed ID: 11108256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intracerebroventricular injection of dynorphin, leumorphin and alpha neo-endorphin on operant feeding in pigs.
    Baldwin BA; de la Riva C; Ebenezer IS
    Physiol Behav; 1990 Dec; 48(6):821-4. PubMed ID: 1982360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Centrally administered interleukin-1 beta sensitizes to the central pressor action of angiotensin II.
    Ufnal M; Dudek M; Zera T; SzczepaƄska-Sadowska E
    Brain Res; 2006 Jul; 1100(1):64-72. PubMed ID: 16765325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.